Louisiana 2018 Regular Session

Louisiana Senate Bill SB477

Introduced
3/22/18  
Introduced
3/22/18  
Engrossed
4/5/18  
Engrossed
4/5/18  
Refer
4/6/18  
Report Pass
4/17/18  
Enrolled
5/18/18  
Enrolled
5/18/18  
Chaptered
5/30/18  

Caption

Provides for electronic prescribing of noncontrolled legend drugs. (8/1/18)

Impact

The enactment of SB 477 is expected to modernize the way prescriptions are handled within institutional healthcare facilities. By allowing for bidirectional electronic transmission of chart orders, it minimizes paperwork and the potential for errors associated with traditional paper-based prescriptions. This shift is projected to save time for healthcare professionals, allowing them to focus more on patient care rather than administrative tasks. Additionally, the bill emphasizes the importance of maintaining proper documentation, as institutional facilities will be the sole repository for prescribers' signatures, hence ensuring reliable tracking of medications prescribed to patients.

Summary

Senate Bill 477 aims to provide a framework for the electronic prescribing of noncontrolled legend drugs, which includes establishing a definition for 'chart order.' This is intended to streamline the prescribing process for healthcare providers, particularly in institutional settings. The bill facilitates the transmission of prescriptions via electronic means, ensuring compliance with federal regulations set forth by bodies like the Centers for Medicare and Medicaid Services. The introduction of these electronic processes is seen to enhance operational efficiency and improve patient care outcomes in Louisiana's healthcare system.

Sentiment

Overall, the sentiment surrounding SB 477 has been supportive among healthcare professionals who recognize the advantages of adopting electronic prescribing methods. Many healthcare providers and stakeholders have backed the initiative, viewing it as a progressive move that aligns with modern healthcare practices. On the other hand, there may be reservations from certain quarters concerning data privacy and security related to electronic prescriptions. However, the general consensus among proponents is that the potential benefits in terms of efficiency and safety far outweigh these concerns.

Contention

Notable points of contention may arise regarding the implementation of bidirectional transmission and whether institutional facilities can adequately meet compliance requirements set forth by federal regulations. There may also be debate over how the bill's provisions interact with existing laws related to patient privacy and healthcare record management. Additionally, the legislations' implications for smaller facilities that may lack resources to adapt quickly to electronic systems could also lead to discussions about equity in healthcare delivery.

Companion Bills

No companion bills found.

Previously Filed As

LA SB189

Provides relative to electronic prescribing of noncontrolled legend drugs. (8/1/18)

LA SB368

Provides relative to mandatory use of electronic prescriptions. (8/1/18)

LA A1853

Requires all prescriptions be transmitted electronically, subject to certain exceptions.

LA A4114

Requires all prescriptions be transmitted electronically, subject to certain exceptions.

LA HB284

Provides relative to prescribing and dispensing of opioid drugs

LA SB223

Allows the use of electronic prescribing. (gov sig)

LA H1297

Electronic Prescribing

LA HB548

Requires that the prescribers transmit prescriptions for opioids to pharmacies electronically (EG SEE FISC NOTE SG EX See Note)

LA SB192

Provides for nurse practitioners and licensure by the Louisiana State Board of Medical Examiners. (1/1/14) (2/3 - CA7s2.1(A)) (OR INCREASE SG EX See Note)

LA SB90

Provides relative to a voluntary nonopioid directive form. (8/1/18) (EN SEE FISC NOTE SG RV See Note)

Similar Bills

No similar bills found.